The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Phenylketonuria Treatment Market Research Report 2024

Global Phenylketonuria Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1894903

No of Pages : 78

Ask Your Query

Synopsis

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.

The global Phenylketonuria Treatment market was valued at US$ 1334 million in 2023 and is anticipated to reach US$ 1741.5 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Phenylketonuria Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylketonuria Treatment.

Report Scope

The Phenylketonuria Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylketonuria Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phenylketonuria Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • American Gene Technologies
  • Dimension Therapeutics
  • BioMarin Pharmaceutical
  • Synthetic Biologics
  • Codexis
  • SOM Innovation Biotech
  • Daiichi Sankyo
  • Erytech Pharma

Segment by Type

  • Drugs
  • Dietary Supplement

Segment by Application

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Pediatric Clinics

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phenylketonuria Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenylketonuria Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Dietary Supplement
1.3 Market by Application
1.3.1 Global Phenylketonuria Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.3.5 Pediatric Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phenylketonuria Treatment Market Perspective (2019-2030)
2.2 Phenylketonuria Treatment Growth Trends by Region
2.2.1 Global Phenylketonuria Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phenylketonuria Treatment Historic Market Size by Region (2019-2024)
2.2.3 Phenylketonuria Treatment Forecasted Market Size by Region (2025-2030)
2.3 Phenylketonuria Treatment Market Dynamics
2.3.1 Phenylketonuria Treatment Industry Trends
2.3.2 Phenylketonuria Treatment Market Drivers
2.3.3 Phenylketonuria Treatment Market Challenges
2.3.4 Phenylketonuria Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phenylketonuria Treatment Players by Revenue
3.1.1 Global Top Phenylketonuria Treatment Players by Revenue (2019-2024)
3.1.2 Global Phenylketonuria Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Phenylketonuria Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phenylketonuria Treatment Revenue
3.4 Global Phenylketonuria Treatment Market Concentration Ratio
3.4.1 Global Phenylketonuria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenylketonuria Treatment Revenue in 2023
3.5 Phenylketonuria Treatment Key Players Head office and Area Served
3.6 Key Players Phenylketonuria Treatment Product Solution and Service
3.7 Date of Enter into Phenylketonuria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phenylketonuria Treatment Breakdown Data by Type
4.1 Global Phenylketonuria Treatment Historic Market Size by Type (2019-2024)
4.2 Global Phenylketonuria Treatment Forecasted Market Size by Type (2025-2030)
5 Phenylketonuria Treatment Breakdown Data by Application
5.1 Global Phenylketonuria Treatment Historic Market Size by Application (2019-2024)
5.2 Global Phenylketonuria Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phenylketonuria Treatment Market Size (2019-2030)
6.2 North America Phenylketonuria Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Phenylketonuria Treatment Market Size by Country (2019-2024)
6.4 North America Phenylketonuria Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phenylketonuria Treatment Market Size (2019-2030)
7.2 Europe Phenylketonuria Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Phenylketonuria Treatment Market Size by Country (2019-2024)
7.4 Europe Phenylketonuria Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phenylketonuria Treatment Market Size (2019-2030)
8.2 Asia-Pacific Phenylketonuria Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Phenylketonuria Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Phenylketonuria Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phenylketonuria Treatment Market Size (2019-2030)
9.2 Latin America Phenylketonuria Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Phenylketonuria Treatment Market Size by Country (2019-2024)
9.4 Latin America Phenylketonuria Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phenylketonuria Treatment Market Size (2019-2030)
10.2 Middle East & Africa Phenylketonuria Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Phenylketonuria Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Phenylketonuria Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 American Gene Technologies
11.1.1 American Gene Technologies Company Detail
11.1.2 American Gene Technologies Business Overview
11.1.3 American Gene Technologies Phenylketonuria Treatment Introduction
11.1.4 American Gene Technologies Revenue in Phenylketonuria Treatment Business (2019-2024)
11.1.5 American Gene Technologies Recent Development
11.2 Dimension Therapeutics
11.2.1 Dimension Therapeutics Company Detail
11.2.2 Dimension Therapeutics Business Overview
11.2.3 Dimension Therapeutics Phenylketonuria Treatment Introduction
11.2.4 Dimension Therapeutics Revenue in Phenylketonuria Treatment Business (2019-2024)
11.2.5 Dimension Therapeutics Recent Development
11.3 BioMarin Pharmaceutical
11.3.1 BioMarin Pharmaceutical Company Detail
11.3.2 BioMarin Pharmaceutical Business Overview
11.3.3 BioMarin Pharmaceutical Phenylketonuria Treatment Introduction
11.3.4 BioMarin Pharmaceutical Revenue in Phenylketonuria Treatment Business (2019-2024)
11.3.5 BioMarin Pharmaceutical Recent Development
11.4 Synthetic Biologics
11.4.1 Synthetic Biologics Company Detail
11.4.2 Synthetic Biologics Business Overview
11.4.3 Synthetic Biologics Phenylketonuria Treatment Introduction
11.4.4 Synthetic Biologics Revenue in Phenylketonuria Treatment Business (2019-2024)
11.4.5 Synthetic Biologics Recent Development
11.5 Codexis
11.5.1 Codexis Company Detail
11.5.2 Codexis Business Overview
11.5.3 Codexis Phenylketonuria Treatment Introduction
11.5.4 Codexis Revenue in Phenylketonuria Treatment Business (2019-2024)
11.5.5 Codexis Recent Development
11.6 SOM Innovation Biotech
11.6.1 SOM Innovation Biotech Company Detail
11.6.2 SOM Innovation Biotech Business Overview
11.6.3 SOM Innovation Biotech Phenylketonuria Treatment Introduction
11.6.4 SOM Innovation Biotech Revenue in Phenylketonuria Treatment Business (2019-2024)
11.6.5 SOM Innovation Biotech Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Phenylketonuria Treatment Introduction
11.7.4 Daiichi Sankyo Revenue in Phenylketonuria Treatment Business (2019-2024)
11.7.5 Daiichi Sankyo Recent Development
11.8 Erytech Pharma
11.8.1 Erytech Pharma Company Detail
11.8.2 Erytech Pharma Business Overview
11.8.3 Erytech Pharma Phenylketonuria Treatment Introduction
11.8.4 Erytech Pharma Revenue in Phenylketonuria Treatment Business (2019-2024)
11.8.5 Erytech Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock